[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342242-105":59,"doc-detail-342242-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-prognostic-value-of-vascular-endothelial-growth-factor-in-endometrial-cancer-a-protocol-for-systematic-review-and-meta-analysis","The prognostic value of vascular endothelial growth factor in endometrial cancer - A protocol for systematic review and meta-analysis","","High vascular endothelial growth factor (VEGF) expression in tumors is linked to poor outcomes in many cancers, yet its prognostic relevance in endometrial cancer remains uncertain. This protocol describes a systematic review and meta-analysis to quantify the effect of VEGF on patient survival. Searches across PubMed, Medline, Web of Science, and CNKI will evaluate hazard ratios and odds ratios with 95% confidence intervals, plus assessment of publication bias.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-prognostic-value-of-vascular-endothelial-growth-factor-in-endometrial-cancer-a-protocol-for-systematic-review-and-meta-analysis/342242/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-prognostic-value-of-vascular-endothelial-growth-factor-in-endometrial-cancer-a-protocol-for-systematic-review-and-meta-analysis/342242.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is VEGF’s prognostic role in endometrial cancer controversial?","Question",{"text":112,"@type":113},"Evidence across studies is inconsistent: some report VEGF as negatively associated with survival, while others find no significant link. This disagreement drives the need for a meta-analysis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases will be searched for eligible studies?",{"text":117,"@type":113},"PubMed, Medline, Web of Science, and the China National Knowledge Infrastructure (CNKI) will be searched to collect studies meeting inclusion criteria.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes will the review use to assess the prognostic value of VEGF?",{"text":121,"@type":113},"Combined hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs) will be calculated to relate high VEGF expression to overall survival and other survival endpoints.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342242,1790173929,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","®  \nSystematic Review and Meta-Analysis   \nThe prognostic value of vascular endothelial growth factor in endometrial cancer A protocol for systematic review and meta-analysis  \nBao Qiang, MD, PhDa , YiFan Kang, MD, PhDa , JiaoLin Yang, BSb , HuanCheng Su, MD, PhDb , Zhe Wang, MD, PhDb , ChunMei Zhang, MD, PhDb , SanYuan Zhang, MD, PhDb ,*  \n\n| Abstract\u003Cbr>Background: A large number of studies have shown that high expression of vascular endothelial growth factor (VEGF) in cancer tissues is associated with poor prognosis of various cancers. However, this finding in endometrial cancer is controversial. Therefore, this meta-analysis aimed to explore the effects of VEGF on survival in patients with endometrial cancer.\u003Cbr>Methods: Four databases of PubMed, Medline, Web of Science, and China National Knowledge Infrastructure were searched to collect literature that met the inclusion criteria. The association between high VEGF expression and survival outcomes and clinicopathological features of patients with cancer was evaluated by calculating the combined hazard ratio (HR), odds ratio (OR), and 95% confidence interval (CI) . The Begg test was used to assess publication bias.\u003Cbr>Results: A total of 11 studies were included, involving 1251 patients. The results showed that compared with low VEGF expression, high VEGF expression was significantly associated with shorter overall survival (HR = 2.44, 95% CI = 1.15–5. 16, I2 = 80%, P = .02) and disease-specific survival (HR = 7.87, 95% CI = 1.70–36.44, I2 = 64%, P = .008) but not with disease-free survival (HR = 1.45, 95% CI = 0.70–3.02, I2 = 68%, P = .32) . In addition, VEGF expression is higher in patients with advanced stage (OR = 3.70, 95% CI = 2.22–6. 19, P \u003C .001), lower histological differentiation (OR = 2.08, 95% CI = 1.22–3.55, P = .007), and lymph node metastasis (OR = 5.42, 95% CI = 2.35–5. 11, P \u003C .001) .\u003Cbr>Conclusion: High VEGF expression can predict poor prognosis and poor clinicopathological features in patients with endometrial cancer, and it may be a valuable new indicator to evaluate the prognosis of patients with endometrial cancer.\u003Cbr>Abbreviations: CI = confidence interval, DFS = disease-free survival, DSS = disease-specific survival, HR = hazard ratio, NOS = Newcastle-Ottawa Scale, OS = overall survival, VEGF = vascular endothelial growth factor |\n| --- |\n| Keywords: endometrial cancer, endothelial growth factor, meta-analysis, prognosis, survive, vascular |\n\n1. Introduction  \nEndometrial cancer is one of the most common malignant tumors in women. [1] The number of patients with endometrial cancer in the United States has been reported to be increasing from 2015 to 2019, with an estimated 66,200 new cancer cases and 13,030 deaths in 2023.[2] In recent years, although the 5-year survival rate of endometrial cancer has been well improved, the risk of recurrence and death is still very high, especially for advanced patients, and even in early patients, the recurrence rate can reach 30%,[3] resulting in poor prognosis of patients. With the development of molecular biology, molecular typing plays a significant guiding role in the treatment and prognosis of endometrial cancer.[4] However, due to the expensive and time-consuming nature of these techniques, their application is limited. Therefore, there is a need to find new  \nThe authors have no funding and conflicts of interest to disclose. The datasets generated during and/or analyzed during the current study are publicly available.  \na Shanxi Medical University, Taiyuan, Shanxi Province, China, b First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.  \n* Correspondence: SanYuan Zhang, First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China (e-mail: [17835152905@163.com](17835152905@163.com)).  \nsimpler and more accurate biomarkers to predict the prognosis of endometrial cancer and to develop new therapeutic targets to improve patient outcomes.  \nVascular endothelial growth fact","cbCaiopfR3PA4D58","https://ap.wps.com/l/cbCaiopfR3PA4D58","pdf",857774,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n## Keywords\n# Introduction","[{\"question\":\"Why is VEGF’s prognostic role in endometrial cancer controversial?\",\"answer\":\"Evidence across studies is inconsistent: some report VEGF as negatively associated with survival, while others find no significant link. This disagreement drives the need for a meta-analysis.\"},{\"question\":\"Which databases will be searched for eligible studies?\",\"answer\":\"PubMed, Medline, Web of Science, and the China National Knowledge Infrastructure (CNKI) will be searched to collect studies meeting inclusion criteria.\"},{\"question\":\"What outcomes will the review use to assess the prognostic value of VEGF?\",\"answer\":\"Combined hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs) will be calculated to relate high VEGF expression to overall survival and other survival endpoints.\"}]","The prognostic value of vascular endothelial growth factor in endometrial cancer - A protocol for systematic review and meta-analysis | PDF",1790045877,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36bb88f5c3277893fcfce5748be311e2.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dddcb2346b605d631971bc1b09df552.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad878d0e0713a714b050ad7bd6c65287.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f82bfdfd1f1de04d61ca1479bed2b90.webp",980,1306]